Phase I trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

被引：2
|
作者：
Kao, J. [1 ]
Packer, S. H. [1 ]
Teng, M. [1 ]
Gupta, V. [1 ]
Misiukiewicz, K. [1 ]
Genden, E. M. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5561
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 Trial of Concurrent Erlotinib, Celecoxib, and Reirradiation for Recurrent Head and Neck Cancer
    Kao, Johnny
    Genden, Eric M.
    Chen, Chien-Ting
    Rivera, Michael
    Tong, Charles C. L.
    Misiukiewicz, Kryztof
    Gupta, Vishal
    Gurudutt, Vivek
    Teng, Marita
    Packer, Stuart H.
    CANCER, 2011, 117 (14) : 3173 - 3181
  • [2] Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer
    Cohen, Ezra E. W.
    Rosine, Dominique
    Haraf, Daniel J.
    Loh, Elwyn
    Shen, Liji
    Lusinchi, Antoine
    Vokes, Everett E.
    Bourhis, Jean
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (03): : 678 - 684
  • [3] INITIAL RESULTS OF A PHASE I DOSE-ESCALATION TRIAL OF CONCURRENT AND MAINTENANCE ERLOTINIB AND REIRRADIATION FOR RECURRENT AND NEW PRIMARY HEAD-AND-NECK CANCER
    Rusthoven, Kyle E.
    Feigenberg, Steven J.
    Raben, David
    Kane, Madeleine
    Song, John I.
    Nicolaou, Nicos
    Mehra, Ranee
    Burtness, Barbara
    Ridge, John
    Swing, Robyn
    Lango, Miriam
    Cohen, Roger
    Jimeno, Antonio
    Chen, Changhu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04): : 1020 - 1025
  • [4] IMRT Reirradiation with Concurrent Cetuximab Immunotherapy in Recurrent Head and Neck Cancer
    Zwicker, Felix
    Roeder, Falk
    Thieke, Christian
    Timke, Carmen
    Muenter, Marc W.
    Huber, Peter E.
    Debus, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (01) : 32 - 38
  • [5] Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer
    Spencer, S
    Wheeler, R
    Peters, G
    Meredith, R
    Beenken, S
    Nabel, L
    Wooten, A
    Soong, SJ
    Salter, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (02): : 118 - 122
  • [6] Reirradiation for recurrent head and neck cancer
    Patel, Pretesh R.
    Salama, Joseph K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (09) : 1177 - 1189
  • [7] REIRRADIATION FOR RECURRENT HEAD AND NECK CANCER
    Jurado, E.
    Jeronimo, P.
    Rubio, M.
    Ordonez, R.
    Acuna, M.
    Ortiz, M. J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S328 - S329
  • [8] Initial Results of a Phase I Dose Escalation Trial of Concurrent and Maintenance Erlotinib and Re-irradiation for Recurrent and New Primary Head and Neck Cancer
    Rusthoven, K. E.
    Feigenberg, S.
    Raben, D.
    Kane, M.
    Song, J.
    Nicolaou, N.
    Mehra, R.
    Burtness, B.
    Swing, R.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S408 - S408
  • [9] Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic
    Saba, Nabil F.
    Hurwitz, Selwyn J.
    Kono, Scott A.
    Yang, Chung S.
    Zhao, Yang
    Chen, Zhengjia
    Sica, Gabe
    Mueller, Susan
    Moreno-Williams, Rachel
    Lewis, Melinda
    Grist, William
    Chen, Amy Y.
    Moore, Charles E.
    Owonikoko, Taofeek K.
    Ramalingam, Suresh
    Beitler, Jonathan J.
    Nannapaneni, Sreenivas
    Shin, Hyung Ju C.
    Grandis, Jennifer R.
    Khuri, Fadlo R.
    Chen, Zhuo Georgia
    Shin, Dong M.
    CANCER PREVENTION RESEARCH, 2014, 7 (03) : 283 - 291
  • [10] Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer
    Cvek, Jakub
    Knybel, Lukas
    Skacelikova, Eva
    Stransky, Jiri
    Matousek, Petr
    Zelenik, Karol
    Res, Oldrich
    Otahal, Bretislav
    Molenda, Lukas
    Feltl, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (01) : 40 - 46
12345